Company record
Bret R. Rutherford, M.D.
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Bret R. Rutherford, M.D..
Warning letters
-
DrugsBret R. Rutherford, M.D.
FDA warned Dr. Bret R. Rutherford for enrolling ineligible patients in two drug studies by skipping required antidepressant washout.
High risk